Six different hepatitis viruses have now been characterized. Hepatitis B an
d C are the two hepatitis infections that are of greatest concern for surge
ons. Hepatitis B and C share several features that have led to this concern
. Both are blood-borne infections. Both are associated with chronic infecti
on ultimately leading to cirrhosis, portal hypertension, and hepatocellular
carcinoma, and both can be occupational infections for the surgeon after p
ercutaneous injury associated with infected blood. Chronic hepatitis B infe
ction is seen in 1.25 million people in the U.S. It is associated with a tr
ansmission rate to healthcare workers of 25 to 30 per cent following a holl
ow needle stick injury. Five per cent of acute infections result in chronic
disease. It can be effectively prevented as an occupational infection by v
accination with the highly effective hepatitis B vaccine. Chronic hepatitis
C infection is present in nearly 4 million people in the U.S. It has a low
er rate of transmission than hepatitis B following needle stick injury, but
it has a 50 to 80 per cent rate of chronic disease after acute infections.
There is no vaccine for hepatitis C, and only prevention of blood exposure
will avoid the risks of this occupational infection. Other hepatitis virus
es are likely to be identified. Prevention of blood exposure, by the better
use of barriers in the operating room and modification of surgical techniq
ues, is recommended to prevent occupational infection from both known and u
nknown blood-borne viruses from the surgical patient.